When a patient visits clinics like medicalcannabis.co.uk or Releaf cannabis clinic, they often hear that their prescription is tailored to the individual. But what does this really mean? Why can’t every patient receive the same standardized product? Understanding this requires delving into the differences between licensed and unlicensed medicines, the role of named-patient specials, and the specialist prescribing practices that clinics must follow under the watchful eye of regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA).
Understanding Licensed vs Unlicensed Medicines
In the UK, medicines are generally classified as either licensed or unlicensed. This distinction lies at the heart of why many clinical prescriptions are individualized.
- Licensed Medicines: These are products that have been granted a marketing authorisation by the MHRA. This means they have undergone rigorous testing — including clinical trials — demonstrating safety, efficacy, and quality before they can be prescribed. Licensed medicines come with standardised information on dosages, indications, and possible side effects. Unlicensed Medicines: These products have not received such formal approval and are often referred to as specials. This category includes named-patient specials, which are medicines prepared or imported specifically for an individual patient on the basis of a clear clinical need that licensed products cannot meet.
Since licensed medicines are standardised products, they typically work well for a broad population. However, many patients seen by specialist clinics require something outside these standard options.
What Is a Named-Patient Special?
The term named-patient special (NPS) refers to an unlicensed medicine prepared or named patient specials UK rules imported specifically for one person. The prescription is based on an individual clinical decision by the specialist prescriber who carefully considers the patient's unique needs.
Aspect Licensed Medicine Named-Patient Special (Unlicensed) Approval Status MHRA Licensed Not MHRA Licensed Standardisation Standardised Dosage/Formulation Customized Formulation or Dosage Prescribing Approach General Indications Tailored to Individual Patient Supply Route Commercial Supply Specialist Manufacture or ImportNamed-patient specials allow clinicians the flexibility to respond to medical complexity, allergy, formulation preferences, or dosing regimes that licensed products cannot accommodate. For example, at clinics such as the Releaf cannabis clinic, where cannabinoid-based medicines are often prescribed, the products used are frequently unlicensed specials tailored by experienced prescribers.
Specialist Prescribing and Private Clinic Access
One reason prescriptions are tailored is because only specially trained clinicians have the expertise to decide when unlicensed specials are appropriate. The process includes:
Conducting a thorough clinical assessment of the patient. Reviewing available licensed options and determining if they meet the patient’s needs. Deciding if a named-patient special is medically justified. Prescribing the medicine with necessary legal compliance.Often, patients access these specialist prescribers in private clinics. The NHS typically restricts use of unlicensed medicines due to cost and risk, so private providers, such as medicalcannabis.co.uk, fill this need. The tailored approach helps in managing complex conditions where off-the-shelf drugs do not suffice.
The Role of Authorised Manufacturers and Importers
Another key factor in tailoring prescriptions is sourcing. Unlicensed specials are usually produced by authorised manufacturers or imported from reputable suppliers who comply with MHRA standards even if the medicine is not fully licensed. This ensures the products meet quality and safety benchmarks.
For example, manufacturers of cannabis-based medicines must meet strict guidelines on purity, cannabinoid profiles, and labelling. Clinics sourcing from these trusted providers can individualise dosage strength and product formulation for each patient without compromising safety.
Why Prescriptions Are ‘Not Standardised Product Choices’
When a clinic states that the prescription is tailored to the individual, this emphasises that the medication chosen isn’t a one-size-fits-all product. Several reasons contribute:
- Patient variability: Differences in metabolism, disease state, or past medicine response demand personalised doses. Formulation flexibility: The ability to modify excipients, cannabinoid ratios, or delivery form suits patient preferences or tolerances. Legal compliance: Following MHRA guidance on unlicensed specials means prescriptions must reflect justifiable clinical need rather than broad indications.
Therefore, these prescriptions are inherently customised rather than selected from standard licensed medicines covering the common population.
Additional Resources: Pharma Journal 'Listen' Audio Option and Site Subscription
If you want to delve deeper into understanding how individual clinical decisions influence prescribing, the Pharma Journal offers an excellent ‘Listen’ audio option. This resource breaks down complex pharmaceutical regulatory topics in accessible language. It’s particularly helpful for clinicians and patients navigating the nuances of licensed vs unlicensed medicines.
You can also stay updated on evolving guidance and industry news by subscribing to their site subscription form. These updates are invaluable for maintaining awareness of policy changes issued by the MHRA or innovative suppliers offering named-patient special access.
Summary: Why Tailored Prescriptions Matter
- The UK strictly regulates medicines through the MHRA, requiring licences for standardised medicines. Named-patient specials offer personalised options where licensed medicines fall short. Specialist prescribers in private clinics assess individual clinical needs before tailoring prescriptions. Authorised manufacturers and importers play a vital role in providing safe, quality unlicensed products. Because of these factors, patient prescriptions are tailored, not standardised product choices.
Next time you hear a clinic say your prescription is individually tailored, remember it’s about clinical judgement, legal frameworks, and quality assurances coming together to provide the safest, most effective medicine specifically for you.
